HEPARIN INDUCED THROMBOCYTOPENIA: A REVIEW

被引:0
作者
Voican, Irina [1 ]
Onisai, Minodora [2 ]
Nicolescu, Anca [1 ]
Vladareanu, Ana Maria [2 ]
Vladareanu, Radu [3 ]
机构
[1] Emergency Univ Hosp, Dept Hematol, Bucharest 050098, Romania
[2] Carol Davila Univ Med & Pharm, Dept Hematol, Bucharest 020956, Romania
[3] Elias Emergency Univ Hosp, Dept Obstet Gynecol, Bucharest 0114611, Romania
关键词
heparin-induced thrombocytopenia; thrombosis; alternative anticoagulants; MOLECULAR-WEIGHT HEPARIN; INTENSIVE-CARE PATIENTS; FONDAPARINUX; ANTIBODIES; RISK; HIT; RIVAROXABAN; THROMBOSIS; DIAGNOSIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Heparin-induced thrombocytopenia (HIT) is a rare but serious complication of heparin use. It is a prothrombotic, antibody-mediated condition in which thrombocytopenia associates thrombosis in a clinical picture that is often challenging for the clinician because of the difficulties of diagnosis and of therapy as well. In daily practice, HIT diagnosis relies mostly on clinical aspects and immunologic assays as the functional tests are not routinely performed, which along with the clinician's fear not to miss the diagnosis have made this condition to be overestimated nowadays. The aim of this article is to review the main diagnosis and management aspects of this dangerous complication in the light of the increasing use of heparin in a wider variety of clinical settings.
引用
收藏
页码:773 / 784
页数:12
相关论文
共 39 条
  • [1] Thrombosis in Suspected Heparin-induced Thrombocytopenia Occurs More Often with High Antibody Levels
    Baroletti, Steven
    Hurwitz, Shelley
    Conti, Nicole A. S.
    Fanikos, John
    Piazza, Gregory
    Goldhaber, Samuel Z.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2012, 125 (01) : 44 - 49
  • [2] Burch Micah, 2012, Proc (Bayl Univ Med Cent), V25, P13
  • [3] The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients
    Crowther, Mark Andrew
    Cook, Deborah J.
    Albert, Martin
    Williamson, David
    Meade, Maureen
    Granton, John
    Skrobik, Yoanna
    Langevin, Stephan
    Mehta, Sangeeta
    Hebert, Paul
    Guyatt, Gordon H.
    Geerts, William
    Rabbat, Christian
    Douketis, James
    Zytaruk, Nicole
    Sheppard, Joanne
    Greinacher, Andreas
    Warkentin, Theodore E.
    [J]. JOURNAL OF CRITICAL CARE, 2010, 25 (02) : 287 - 293
  • [4] How I treat heparin-induced thrombocytopenia
    Cuker, Adam
    Cines, Douglas B.
    [J]. BLOOD, 2012, 119 (10) : 2209 - 2218
  • [5] Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis
    Greinacher, A
    Farner, B
    Kroll, H
    Kohlmann, T
    Warkentin, TE
    Eichler, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) : 132 - 135
  • [6] Thrombocytopenia in the Intensive Care Unit Patient
    Greinacher, Andreas
    Selleng, Kathleen
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 135 - 143
  • [7] National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population
    Hutchison, Colin A.
    Dasgupta, Indranil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (06) : 1680 - 1684
  • [8] Kauel K, 2008, J THROMB HAEMOST, V6, P2160
  • [9] Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies
    Krauel, Krystin
    Hackbarth, Christine
    Fuerll, Birgitt
    Greinacher, Andreas
    [J]. BLOOD, 2012, 119 (05) : 1248 - 1255
  • [10] Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux
    Kuo, KHM
    Kovacs, MJ
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 93 (05) : 999 - 1000